SAN FRANCISCO, Nov. 3, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq:NKTR) today reported financial results for the third quarter ended September 30, 2022.
Read more at prnewswire.comNektar Therapeutics Reports Third Quarter 2022 Financial Results
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here